American pharmaceutical company AbbVie has marked its entry into the Indian cancer drugs segment with Venetoclax used to ...

Through the launch of Venetoclax for the treatment of both Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL ...

Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia ... has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth.

US drug maker AbbVie has launched its key leukemia drug, Venetoclax, in India, marking its entry into the country's oncology ...

Adding venetoclax to decitabine-cedazuridine significantly enhanced response rates in patients with higher-risk ...

Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at ...

Master Trial is at the heart of LLS's Dare to Dream Project to transform treatment and care for kids with blood cancer WASHINGTON, April 21, 2025 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) ...

Aurobindo Pharma's shares rose nearly 3% after its subsidiary, Eugia Pharma, received USFDA approval to market Dasatinib ...

Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously ... of disease was ultimately complicated by acute disseminated encephalomyelitis and death.

After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the ...

In a review of 182 cancer studies, authors failed to report outcome data by sex in 90% of cases, even though men develop ...